![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 23, 21124-21128, June 6, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







¶
From the
Department of Biochemistry and Montreal Joint Center for Structural Biology, McGill University, Montreal, Quebec H3G 1Y6, Canada and
GeminX Biotechnologies Inc., Place du Parc, Montreal, Quebec H2X 4A5, Canada
The structure of human BCL-w, an anti-apoptotic member of the BCL-2 family, was determined by triple-resonance NMR spectroscopy and molecular modeling. Introduction of a single amino acid substitution (P117V) significantly improved the quality of the NMR spectra obtained. The cytosolic domain of BCL-w consists of 8
-helices, which adopt a fold similar to that of BCL-xL, BCL-2, and BAX proteins. Pairwise root meant square deviation values were less than 3 Å for backbone atoms of structurally equivalent regions. Interestingly, the C-terminal helix
8 of BCL-w folds into the BH3-binding hydrophobic cleft of the protein, in a fashion similar to the C-terminal transmembrane helix of BAX. A peptide corresponding to the BH3 region of the pro-apoptotic protein, BID, could displace helix
8 from the BCL-w cleft, resulting in helix unfolding. Deletion of helix
8 increased binding affinities of BCL-w for BAK and BID BH3-peptides, indicating that this helix competes for peptide binding to the hydrophobic cleft. These results suggest that although the cytosolic domain of BCL-w exhibits an overall structure similar to that of BCL-xL and BCL-2, the unique organization of its C-terminal helix may modulate BCL-w interactions with pro-apoptotic binding partners.
Received for publication, February 19, 2003 , and in revised form, March 21, 2003.
The atomic coordinates and structure factors (code 1MK3
* This work was supported in part by a Natural Science and Engineering Research Council of Canada partnership grant (to K. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Biochemistry, McGill University, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada. Tel.: 514-398-7287; Fax: 514-398-7384; E-mail: kalle.gehring{at}mcgill.ca.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. R. Shoemaker, A. Oleksijew, J. Bauch, B. A. Belli, T. Borre, M. Bruncko, T. Deckwirth, D. J. Frost, K. Jarvis, M. K. Joseph, et al. A Small-Molecule Inhibitor of Bcl-XL Potentiates the Activity of Cytotoxic Drugs In vitro and In vivo. Cancer Res., September 1, 2006; 66(17): 8731 - 8739. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aouacheria, F. Brunet, and M. Gouy Phylogenomics of Life-Or-Death Switches in Multicellular Animals: Bcl-2, BH3-Only, and BNip Families of Apoptotic Regulators Mol. Biol. Evol., December 1, 2005; 22(12): 2395 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Day, L. Chen, S. J. Richardson, P. J. Harrison, D. C. S. Huang, and M. G. Hinds Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands J. Biol. Chem., February 11, 2005; 280(6): 4738 - 4744. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Oh, S. Barbuto, N. Meyer, R.-S. Kim, R. J. Collier, and S. J. Korsmeyer Conformational Changes in BID, a Pro-apoptotic BCL-2 Family Member, upon Membrane Binding: A SITE-DIRECTED SPIN LABELING STUDY J. Biol. Chem., January 7, 2005; 280(1): 753 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, S. M. Lapolla, M. G. Annis, M. Truscott, G. J. Roberts, Y. Miao, Y. Shao, C. Tan, J. Peng, A. E. Johnson, et al. Bcl-2 Homodimerization Involves Two Distinct Binding Surfaces, a Topographic Arrangement That Provides an Effective Mechanism for Bcl-2 to Capture Activated Bax J. Biol. Chem., October 15, 2004; 279(42): 43920 - 43928. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-M. Gong, J. Choi, C. M. Franzin, D. Zhai, J. C. Reed, and F. M. Marassi Conformation of Membrane-associated Proapoptotic tBid J. Biol. Chem., July 9, 2004; 279(28): 28954 - 28960. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Reed, K. S. Doctor, and A. Godzik The Domains of Apoptosis: A Genomics Perspective Sci. Signal., June 29, 2004; 2004(239): re9 - re9. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schinzel, T. Kaufmann, M. Schuler, J. Martinalbo, D. Grubb, and C. Borner Conformational control of Bax localization and apoptotic activity by Pro168 J. Cell Biol., March 29, 2004; 164(7): 1021 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Willis, C. L. Day, M. G. Hinds, and D. C.S. Huang The Bcl-2-regulated apoptotic pathway J. Cell Sci., October 15, 2003; 116(20): 4053 - 4056. [Full Text] [PDF] |
||||
![]() |
J. Wilson-Annan, L. A. O'Reilly, S. A. Crawford, G. Hausmann, J. G. Beaumont, L. P. Parma, L. Chen, M. Lackmann, T. Lithgow, M. G. Hinds, et al. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity J. Cell Biol., September 1, 2003; 162(5): 877 - 888. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |